MolDX: DecisionDx-UM (Uveal Melanoma)

The DecisionDx-UM test is covered only for patients with a confirmed, newly diagnosed uveal melanoma who have no evidence of metastatic disease, to assess metastatic risk and guide surveillance and referral to medical oncology. Use outside this population (eg, patients with metastatic disease or without a confirmed/new diagnosis) is not within the indicated coverage scope.

"DecisionDx-UM is covered for management of patients with a confirmed diagnosis of newly diagnosed uveal melanoma and no evidence of metastatic disease to determine metastatic risk and to guide surv..."

Sign up to see full coverage criteria, indications, and limitations.